14 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 30464040 | Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer. | 2019 Jul | 2 |
2 | 28638478 | 177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice. | 2017 | 2 |
3 | 26460595 | Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities. | 2016 Jan | 1 |
4 | 26552656 | Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer. | 2016 Jun | 3 |
5 | 27228467 | Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer. | 2016 Jun 23 | 3 |
6 | 25956413 | Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen. | 2015 Jun 15 | 3 |
7 | 26169882 | A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. | 2015 Oct | 4 |
8 | 22911263 | PSMA-targeted SPECT agents: mode of binding effect on in vitro performance. | 2013 Mar | 1 |
9 | 23232055 | Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles. | 2013 Jan 15 | 1 |
10 | 23773397 | Rationally designed sulfamides as glutamate carboxypeptidase II inhibitors. | 2013 Nov | 1 |
11 | 22670265 | A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent. | 2012 Jun 1 | 3 |
12 | 21219587 | N-substituted glutamyl sulfonamides as inhibitors of glutamate carboxypeptidase II (GCP2). | 2011 Apr | 1 |
13 | 18023582 | Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen. | 2008 Jan 1 | 1 |
14 | 17869524 | The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen. | 2007 Dec 1 | 2 |